MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Should be stored in tight, light resistant containers and protected from excessive moisture.

Provenance

This compatibility recommendation is derived from Clarityn Allergy 10mg tablets (Bayer Plc) and Loratadine 10mg tablets (Accord Healthcare Ltd).

Stability Notes

Protect from light.

Provenance

This compatibility recommendation is derived from Dexamethasone 2mg tablets (Aspen Pharma Trading Ltd)

Stability Notes

Protect from light.

Provenance

This compatibility recommendation is derived from Dexamethasone 500microgram tablets (Aspire Pharma Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Strattera 100mg capsules (Eli Lilly and Company Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Strattera 18mg capsules (Eli Lilly and Company Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Strattera 25mg capsules (Eli Lilly and Company Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Strattera 40mg capsules (Eli Lilly and Company Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Strattera 60mg capsules (Eli Lilly and Company Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Strattera 80mg capsules (Eli Lilly and Company Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.